If you have normal cholesterol though - we have long known that people with normal cholesterol also have heart attacks. It isn't as common as people who have high cholesterol, but it is still very common for someone normal cholesterol to have a heart attack. We don't really know what to do about this though. This article is saying we should measure inflammation and if found deal with it. Seems reasonable.
What isn't known is if we deal with inflammation will heart attacks go away or if there are more factors. If there are more factors we don't know what they are or if they are worth measuring/treating (though some researchers may have data they are trying to get out here). If dealing with inflammation is good, can we start ignoring cholesterol - another unknown (one for researchers to look into, but the rest of us should for now say no cholesterol is independently important - until data says otherwise)
More in-depth testing would check LDL-P (particle count) and ApoB along with hsCRP.
Though realistically, most people could simply look at their diet and lifestyle and work on improving both before investing in any extra testing. The testing can be useful to catch cases where genetics overwhelm even healthy lifestyles, but in many cases for younger people the testing basically serves as a wake-up call to actually do something about lifestyle and diet problems. It's easier to inspire lifestyle and diet changes when you're staring at bad numbers on the test results and getting a little preview of the consequences of your decisions.
Large bouyant LDL is not associated with CVD risk whereas small dense LDL is.
You can have high HDL, high LDL and low triglycerides. This is a pretty rare pattern, but one where you do not have increase risk of CVD.
In most people, having high LDL is linked to having high small dense LDL and low aounts of large boyant LDL. Hence why LDL is used as a simple risk measure - even though it's wrong.
Statins in trials show benefits for secondary events, but for primary protection statins don't actually work that well.
As for statins not working well in primary prevention, I'm not sure what you mean - the JUPITER trial showed significant risk reductions for primary prevention, for example.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4876179/ https://pubmed.ncbi.nlm.nih.gov/36779348/
This just simply isn't true and we have massive quantities of data pointing towards protection against major vascular events - even in people that we previously would have considered as having "normal" cholesterol. The NLA and AHA has been revising their guidelines to start getting people on statins sooner and to get levels lower for a reason - it works.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
I got a zero, in other words, no blockage at all. When I reviewed my results with a cardiologist, he basically said, "Some people just have high cholesterol, and it's not a problem. You're probably one of them." I also separately got tested for the type of LDL particles, and mine were primarily composed of big, floaty ones that aren't associated with increased risk (or at least that's what the test result notes said).
I'll do the calcium score every 5 years just to keep tabs on it. But thankfully I didn't start a needless medication regimen.
LDL while clearly not telling the whole story is a great first line defense at population levels because it's easy and cheap (similar to BMI). If you just throw Statins at everybody with high LDL you're going to improve health outcomes, and historically providers and researchers have considered statins to be effectively "free" (both in actual cost and in side effects).
In developed countries where the equipment for this test is readily available, individual patients should absolutely request it even if paying out of pocket, if for nothing more than their own peace of mind.
I'm a layman but I have come to conclude that the AHA's guidelines on when to recommend the CAC test are too conservative. Definitive knowledge of the underlying pathology (or lack thereof) seems like it would be useful both for people with exceptionally high and exceptionally low scores. Even if in a vast majority of cases the treatment plan would be similar (just give them statins) more knowledge seems better on an individual treatment level.
[0] https://www.heart.org/en/health-topics/heart-attack/diagnosi...
Particularly for people below ~45 with significant plaque buildup, calcium scores are often 0 or very low, because all of the plaque is soft.
This is one of the reasons CACs aren't used much in younger people - that plaque hasn't yet calcified.
Soft plaque is the dangerous stuff, too - most statins actually calcify plaque, but this stabilizes it and prevents it from rupturing and the chunks entering the bloodstream.
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research
https://pubmed.ncbi.nlm.nih.gov/36351849/
A few other more recent papers:
https://pubmed.ncbi.nlm.nih.gov/35498420/
https://www.jacc.org/doi/10.1016/j.jacadv.2024.101109
Note: I'm not a doctor.
Calcium is the end-stage of atherosclerosis. In other words, only advanced atherosclerosis has calcium. The electron beam CT test can, therefore, read zero in people with extensive atherosclerosis, if it is still in the earlier stages. As others note, even early atherosclerosis is bad.
That is why insurance doesn't cover electron beam CT -- it's a crappy test. It provides no reassurance if it's negative, and on a population scale the LDL is far more cost effective and convenient to identify people who need statins.
You might look back at studies from the early statin days, like AFCAPS/TexCAPS, which looked at healthy people like you, whose only risk factor was high cholesterol. The ones who got even the primitive statins of the day lowered their risk of a first coronary event by 37%. That doesn't even tell the whole story, because atherosclerosis can affect any artery in the body. You want your kidneys, eyes, ears, brain, legs, and penis (when present) to work well to the end of your days. Atherosclerosis is a terrible disease.
Just to continue on this line, we also know that people with a genetic disposition for low cholesterol have a significantly lower risk of coronary heart disease than people with ostensibly normal cholesterol levels. It is one of the most proven, obvious correlations (more cholesterol increases the incident of CHD) in medicine.
Some snake-oil merchants, usually pitching a book or supplement, have often tried to muddy the waters by pointing out that someone at death's door often has very low cholesterol (they usually aren't eating, and cancer often "eats" cholesterol and leads to low levels), trying to then extrapolate this out.
You have to understand the point which you’re not yet able to put in your head. Yes it is true that lowering cholesterol lowers cardiovascular disease. No one here is disagreeing with that. What we are explaining is that cholesterol alone does not cause heart disease. It is cholesterol plus inflammation that causes heart disease. I don’t know why this is so hard to understand. Lowering inflammation not only would reduce cardiovascular disease, but also cancer, arthritis and a multitude of other diseases.
interesting idea which I have heard before. However so far as I can tell we don't know if it is true. It seems to fit the evidence that the two are independantly causes of heart attack, when combined it is worse.
maybe someday science will figure this out but it is not easy and so will take a while. Until we do I avoid saying things with high confidence.
Artificially eliminating the firefighters doesn't necessarily mean you've solved most of the problem.
Heart disease is a far more complicated problem than "cholesterol" or "cholesterol + inflammation", but humans and patients mentally gravitate to silver bullet thinking, which makes it really hard to work with. One interesting measure I've encountered is the lipid clearance rate, but it costs something like +$20k to measure and is not something a doctor can order from a lab; it's typically only performed in research settings.
Yes, from a mechanistic standpoint, inflammation is also an important causal factor. Lp(a) is also an important factor for people that are genetically predisposed to high levels - it also deposits plaque, and is one of the reasons ApoB is recommended. Most people don't have worrisome Lp(a) levels but enough do that we've been missing them, and we now also have good treatments for them - PCKS9 inhibitors reduce it by ~1/3rd, and we have Lp(a) specific medications in phase 3 trials that are even stronger.
But we know that statins work. This is some of the most established science in health. I keep seeing claims in these comments from people stating otherwise, but it just doesn't match reality.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
We have MR studies on genetics that further reinforce this idea to a huge degree
https://pubmed.ncbi.nlm.nih.gov/28444290/
We also know that lowering LDL in and of itself lowers inflammation within the arterial wall, though this isn't necessarily reflected in hsCRP. We know that foam cell activation and cytokine signaling increase inflammation at the site of the plaque, which results in further deposition, and these require ApoB particles be depositing plaque there to begin with. Some PCSK9 inhibitors show zero change in hsCRP results yet still show less localized inflammation - due to the significant reduction in LDL-C and Lp(a) particles.
https://www.frontiersin.org/journals/cardiovascular-medicine...
Lowering inflammation also works for reducing events independent of lowering ApoB particles - colchicine works even though it does nothing there - but if we're really trying to stretch the fire analogy, it's more like LDL and Lp(a) are the years of unmaintained brush and flammable debris in a forest, and inflammation is the strong winds. Both can lead to the spread of fire even without the other, fire can still spread even in the absence of both, but having either and especially having both will greatly increase the risk of the fire continuing to spread.
And, we have shown the mechanism of action. Certain cholesterols will build up on artery walls, constraining the flow of blood. When there is too much build up and/or the vessel is too narrow, blood can be constrained too much, causing loss of blood flow and therefore oxygenation. The heart has MANY capillaries and requires a lot of oxygen.
This is really for real.
MR studies looking at genetics show a decrease in cardiovascular events with lower LDL/Lp(a) levels independent of other factors such as hsCRP
https://pubmed.ncbi.nlm.nih.gov/23083789/ https://www.nejm.org/doi/full/10.1056/NEJMoa1604304 https://journals.plos.org/plosmedicine/article%3Fid%3D10.137...
Lp(a), another plaque depositing particle also has been shown in MR to be an independent risk factor for CVD events regardless of hsCRP
https://europepmc.org/article/med/20032323 https://pmc.ncbi.nlm.nih.gov/articles/PMC5483508/ https://www.nejm.org/doi/full/10.1056/NEJMoa1109034
Neat.
>You have to understand the point which you’re not yet able to put in your head
Nowhere did I ever dismiss other causative inputs. All I did was reply to some probably-listen-to-chiropractor people who sure are trying incredibly hard to downplay cholesterol.
Why don’t you stop your appeal to authority arguments and focus on the facts.
It’s not that I haven’t died yet either. My calcium artery score was zero. I have no plaque in my arteries and I’ve had high cholesterol for probably 30 years of my life because of my genetics.
If that is not interesting to you then you have an odd bias. I merely saying that inflammation is the risk factor that matters more than high cholesterol. You can lower cholesterol for someone who has high inflammation and reduce heart disease, but reducing inflammation is more important overall.
This is the stupidest thing I've ever heard in my life.
If one person doesn't die from cancer than cancer is not the problem. Fact. Logic.
Not sure if this is your first day on Earth or what, but YES, there's variances in outcomes. Welcome to Earth and being a human.
My grandfather smoked for 70 years and died peacefully. And what?
You’re comparing cancer to LDL. So you’re literally saying LDL is like cancer in the body. That’s ridiculous. The body does not need cancer, but it does need LDL to transport fats around the body.
And for your grandfather, yes, smoking does not cause cancer, smoking increases the risk of cancer, and cardiovascular disease, but there are other factors that play into that including nutrition and genetics.
Do you understand the distinction between increasing risk and causing?
This is the problem with western medicine, the constant search for a single cause disease because It’s not so complex that a non-holistic person can understand it.
If I was a legitimate scientist, I would look at your grandfather‘s case in curiosity and amazement. What was it that he did that proved him immune to the ravages of smoking? Do you know there were some people that had HIV that did not end up with AIDS? And the good scientist use those anecdotes to find a cure for AIDS and the current treatments that are now making people live long lifetimes with HIV.
Of course the body needs cancer.
Cancer is your own bodies cells. They're essential for you being alive. And, cells with damaged DNA train and hone your immune system.
You have millions of cancer cells in your body right now. Your immune system is killing them as we speak.
If a few happen to slip through, then that's we would say you have cancer. Why might they slip through? Your immune system makes mistakes. Because everything makes mistakes.
> What was it that he did that proved him immune to the ravages of smoking?
Um, nothing?
Is this your first day on Earth? Life is not an algorithm.
Everything is risk, everything is probability. Smoking increases your risk. It doesn't give you anything.
Your HIV and AIDS argument is just fucking stupid. Sorry to be blunt.
Yes, SOME things are A -> B. That is an extremely rare exception to the rule. Extremely. That almost never happens.
Like, if I drive fast, I might die. Might. Its not a garuantee.
I can drive 150 every day and live, or drive 10 and die immediately. That's life. Welcome to risk and probability. That's just how things work.
Having LDL and no heart disease doesn't prove anything to anyone. That doesn't prove LDL doesn't cause heart disease.
This is such a silly statement I'm not sure where to begin. Plenty of people smoke and drink and don't die of issues related to smoking or drinking, but smoking and drinking are bad for you.
Individual response to things varies. No one reasonable is going to say that because such and such person did X, Y, Z things that we know are bad and didn't have a negative outcome that we must flip the script on if those things are bad are not. Exceptions exist for a wide variety of reasons.
> It’s not that I haven’t died yet either. My calcium artery score was zero. I have no plaque in my arteries and I’ve had high cholesterol for probably 30 years of my life because of my genetics.
Calcium score does not tell you how much plaque you have in your arteries - it tells you how much calcified plaque you have in your arteries. This is NOT the same thing. You need a CCTA to tell if you have soft plaque or not.
I'm sorry, but you're just severely misinformed here and spreading all sorts of dangerous misinformation all over the comments here.
The reason we offer the tests as cash pay is that it's the only way we can guarantee the price. In the past, when we've gone through insurance, the insurer's "negotiated rate" for the same exact panel comes out to $1,400-$1,500. If the insurer later decides to deny coverage for any of the tests, it's more expensive for the patient.
The $190 price is negotiated to be pretty low. It includes hs-CRP ($59 by itself online), but also the other major heart health biomarkers: ApoB ($69), Lp(a) ($49), A1c ($39), lipid panel ($59), eGFR ($99), other biomarkers, and a video consultation with a doctor to actually explain the results and what to do about them.
For hs-CRP in particular, it's not covered under the ACA as a preventive benefit, so you would usually need to hit your deductible before insurance kicks in at all. (That's assuming they count it as medically necessary at all -- for example, Aetna's current medical policy for hs-CRP requires 2 risk factors, LDL in a specific range, and overall cardiovascular risk to be in a certain range or the claim would simply be denied). It's possible this will change over time as the ACC/AHA recommend universal screening, and I hope it does, but it's a relatively a slow process since it depends on the US Preventive Services Task Force to issue a formal recommendation.
> In the past, when we've gone through insurance, the insurer's "negotiated rate" for the same exact panel comes out to $1,400-$1,500.
hs-CRP is not going to be a $1500 negotiated rate under any insurance these days. No sane insurance company is going to pay that.
I understand that the negotiated rate you're talking about is for an entire panel of many markers, but most of these are not necessary for a quick screen and many would already be covered by an ACA annual checkup.
> It includes hs-CRP ($59 by itself online),
hs-CRP is $50 right now at privatemdlabs.com before the 25% off coupon they're blasting me with in the pop-up. It appears to be in the $40-45 range at a few other direct lab companies.
I checked privatemdlabs.com, and they're asking $249 for a cardiovascular panel that covers the same biomarkers. So I think our pricing compares pretty favorably, especially when you consider that we offer an MD review.
> hs-CRP is not going to be a $1500 negotiated rate under any insurance these days.
The $1500 insurance price is for the $190 panel. We've actually dealt with this exact situation in the last month, since every so often labs will make a mistake when they process the order (we obviously fix these situations). Perhaps the insurance companies aren't sane (a topic for another day), but this is unfortunately how the system works today.
This is one of those weird horrible traps health insurance puts you into. OP may charge insurance 1500$, insurance may only pay 20%. But that now means they have to charge individuals the full 1500$ price.
So honestly, Cudos to the OP for identifying this trap and then moving to just charging a reasonable flat rate.
https://app.hellogoodlabs.com/book-tests
ApoB $12
LP(a) $20
A1c $ 4
Lipid $ 8
eGFR $30 (Under "Cystatin C with Glomerular Filtration Rate, Estimated (eGFR)")
Total: $74
So no, I wouldn't call $190 "pretty low", lol.https://curitt.as.me/schedule/7b51cc60/appointment/70269915/...
Cash also has the advantage of the person requesting the test not having to disclose it. For example if you're running the test for getting life insurance and need to lower cholesterol you could use the cash tests for this. Using insurance for this will expose the numbers when you grant access to the insurance company to troll through your records.
Decades of plaque accumulation doesn't just go away when you lower your cholesterol.
The question is if people who keep their cholesterol/ApoB low (e.g. Mendellian randomization) have better health outcomes, and the evidence is clear. Lifelong exposure to cholesterol/ApoB mediates atherosclerosis.
I would normally interpret that to mean, lifelong elevated levels of cholesterol/ApoB _decreases_ atherosclerosis.
Is that what you meant?
P1: exposure X is not causally linked to outcome Y if some individuals with lower exposure to X have outcome Y. P2: some individuals with lower exposure to serum cholesterol have heart attacks. C: serum cholesterol is not causally linked to heart attacks.
Because this has some wacky implications:
P1: exposure X is not causally linked to outcome Y if some individuals with lower exposure to X have outcome Y. P2: some individuals with lower exposure to cigarettes have lung cancer. C: smoking is not causally linked to lung cancer.
For example, smokers likely purchase more lighters than non-smokers so there should be some correlation between lighter purchase frequency and lung cancer. But we all know you can't get lung cancer merely from buying lighters.
I’m talking specifically about the claim that because individuals with a low exposure to something don’t necessarily have a given outcome, there is no causal pathway between the exposure and the outcome. It’s not clear to me how what you’ve written speaks to anything regarding that claim.
Not trying to be snarky, I just want to be really clear about the point I’m trying to make here.
But lowering your LDL does not prevent heart disease. There are many many people with normal LDL who have heart attacks.
In fact, it is the norm. And I can’t imagine how many people are being told. They have no heart disease risk just because their LDL is normal. It’s a crime and it needs to be stopped.
https://www.uclahealth.org/news/release/most-heart-attack-pa...
A new national study has shown that nearly 75 percent of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk for a cardiovascular event, based on current national cholesterol guidelines.
Wearing a seatbelt does not prevent death in a car accident. There are many people who wear seatbelts who still perish in car accidents.
While you can find a vocal minority who claim cholesterol is not related to heart disease, the best evidence we have is that it is. A lot of the doctors pushing cholesterol denialism are into quacks, such as Uffe Ravnskov who pivoted from denying a link between LDL and CVD into preaching Vitamin C to treat COVID when that hit the news.
However, it's not the only actor in determining heart attack risk.
LDL is used as a predictor because it is easy to measure not because LDL itself causes heart disease. Lowering LDL doesn't actually do anything on its own, because it is just a proxy metric for the underlying problem.
It's more cranky to shutdown discussions by misrepresenting someone's position as "cholesterol denialism". What does that even mean in this context? Finding better predictors is denialism. Great now we just need a ministry of truth.
Is this some sort of weird philosophical statement? Because, of course, it's completely nonsensical, and completely at odds with all data on this file.
Lowering LDL reduces CVD incident rates, with no other interventions. People with genetically low LDL also have lower CVD incident rates. This is extraordinarily well proven.
So it sure seems -- you know, 100% of medical science -- that lowering LDL does "something".
The human body is a complex machine, however, and CVD is multifactorial, and for CVD to develop the current thinking is that you need inflammation and high cholesterol over decades. Inflammation can be caused by things like high blood pressure and the like. But everyone has inflammation to some degree as a facet of living, and the easiest component of that to treat (not just measure) is LDL.
And yes, there is an industry of cholesterol denialists, among whom there are just loads and loads of chiropractors. These clowns have built armies of poorly informed disciples that run to HN to tell us that cholesterol doesn't matter and lowering LDL doesn't do anything.
I get my CRP measured every year. I have zero inflammation and I am in my late 50s. So not everyone has inflammation.
You’re saying a lot of nonsensical stuff in your comment like high blood pressure causes inflammation , which tells me you are not serious in this discussion. Because that makes absolutely no sense.
It's like saying a flying bullet can't do anything on its own. It is a meaningless statement.
>As I pointed out in another post over 75% of people who have heart attacks have normal LDL.
The actual study authors were advocating for lower LDL guidelines, particularly among the elderly.
A heart attack is the destination, not the journey. What someone's LDL was at admission for a heart attack says literally nothing about their state for the decades before. In actual studies tracking cholesterol, even over a five year period lowering LDL has a potent beneficial effect.
>You’re saying a lot of nonsensical stuff in your comment like high blood pressure causes inflammation , which tells me you are not serious in this discussion
Hypertension can cause endothelial inflammation, leading to blood vessel damage and promoting the release of inflammatory mediators. This is extremely well documented, and it's why getting hypertension under control medically is considered extremely important in the CVD battle. Inflammation and hypertension often are found hand in hand, and there is uncertainty over the cause and the effect, but strangely controlling hypertension alone dramatically reduces inflammation. Weird, right?
>I have zero inflammation
Sorry, but LOL. Not only is that a singular and very narrow test, inflammation is literally just a facet of living. As is oxidization. There isn't a single human alive with "zero inflammation", nor is there anyone that has magically non-odidizing LDL.
No one knowledgeable here is saying that inflammation isn't worth paying attention to, but people acting like because inflammation is also important that LDL does nothing just aren't living in reality.
Your comment about blood pressure actually reveals more about your knowledge here than the person you're replying to.
FDG-PET is a signal we can use to detect tissue inflammation, and we know that higher blood pressure is highly correlated with increased FDG-PET in arterial walls:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6994784/
High blood pressure is also feed-forward loop with Angiotensin, which increases inflammation:
https://pmc.ncbi.nlm.nih.gov/articles/PMC3377325/ https://pmc.ncbi.nlm.nih.gov/articles/PMC4192119/
Blood pressure results in shear stress to your arteries. This results in several things that amplify Angiotensin II and NF-kB activity, including expoosing adhesion molecules which then results in foam cell activation and cytokine signaling, etc.
It is quite well established that high blood pressure will contribute to increased inflammation.
We know that low LDL does not prevent CVD. Therefore we know that you do not need high cholesterol over decades.
https://www.lipidjournal.com/article/S1933-2874%2825%2900317...
That people can still experience a heat attack even with low LDL does not change that fact. We have very large studies showing the efficacy of lowering LDL.
Literally one of the most proven truths in medical science is that LDL levels has an almost directly relationship with CVD risk over the long term. Someone with low cholesterol can of course still have CVD, but their odds are much better than someone with high cholesterol. And of course the damage from cholesterol is additive, so the earlier you control LDL, the more of a benefit.
>A new national study has shown that nearly 75 percent of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk for a cardiovascular event, based on current national cholesterol guidelines.
The damage from high cholesterol happens over decades. Yet the people who actually have heart attacks are often older.
So yes, if gramps spent his life with high cholesterol but now he barely eats and is sedentary, he might have low cholesterol now but that says literally nothing to what you're claiming it does.
Which is it? Does lowering help or not? You've come to the conclusion that it doesn't seem to matter.
The current guidance from the AHA and NLA is that lower is better for as long as possible.
What did I "shout"? What are you even going off about? Don't project your angry fanaticism on others.
Further, your literacy is not my problem. Nothing in my comment was contradictory or confusing to anyone but you.
https://www.uclahealth.org/news/release/most-heart-attack-pa...
And lower cholesterol is not without its own risks. You need cholesterol to make hormones and things like CoQ10, which are important for our health. So what’s better? Lowering oxidative stress and inflammation or lowering cholesterol?
I haven’t seen any clear evidence that low blood cholesterol has actual risks, just hypothesizing. Is there any?
PCSK9 inhibitors when coupled with statin therapy have gotten people to ~10 LDL without negative impact in clinical trials. The body is good at producing cholesterol where it needs it - it doesn't pass the blood brain barrier, yet the brain is full of it. It produces it's own, the same as quite a lot of other tissue
For hormones, de novo synthesis of cholesterol is a thing when it comes to steroidgenesis, as well as recycling and re-uptake. PCSK9 inhibitor studies specifically looked at this because of this concern, and found cortisol/aldosterone/testosterone/estrogen/etc. were not impacted by having very lower levels of LDL-C.
The issue with statins and CoQ10 isn't cholesterol - it's the mevalonate pathway. They block a reductase in the pathway and this results in lower serum CoQ10 levels. Data around if this is of any clinical relevance is a mixed bag, but this is easily supplementable if needed, and should not be a reason to not take life saving medication. PCSK9 inhibitors make large dents in LDL but do not impact CoQ10 levels at all because they do not impact the mevalonate pathway.
https://www.ahajournals.org/doi/10.1161/ATV.0000000000000164 https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/201... https://pubmed.ncbi.nlm.nih.gov/36779348/
As for which is better... lower both. Why wouldn't you want to lower all the causal factors you can? Statins even do this!
I'm not a doctor, but doesn't LDL basically just prevent the body from healing damage to the epithelium, which comes from things like high blood pressure and inflammation? Unless my understanding is wildly off base, it doesn't really make sense that a thing that merely slows down the healing process would be more predictive than the things causing the damage in the first place, given that if you aren't accumulating significant damage then your levels of cholesterol are somewhat moot.
If you're going for more testing, I would definitely suggest the lipofraction.
https://academic.oup.com/eurheartj/article-abstract/46/27/27...
This might dependent on how much you care about false positives and pushing wrong advice to people, but the difference in levels in non Caucasian ethnies in particular is kind of ignored in most directives.
When looking deeper into it, it's a lot more complex than a simple "higher than X is market for Y". For instance:
https://www.ahajournals.org/doi/10.1161/01.atv.19.9.2234
> In conclusion, we have found an ethnic difference in the LDL size distribution, with African Americans having the highest LDL size (“less atherogenic”) and Hispanics having the lowest LDL size; these ethnic differences in LDL size, however, appear to be primarily due to differences in triglyceride and HDL cholesterol among the ethnic groups. Similar variables (triglyceride, HDL cholesterol, insulin resistance, etc) appear to be related to LDL size in these ethnic groups. Last, ethnic differences in LDL size are not consistent with previously reported differences in their risk of CVD or atherosclerosis; in fact, the ethnic differences in LDL size may be opposite the CVD risk differences by ethnic group.
I think LDL is a good biomarker, just not in isolation, and especially not a "one-size fits all" metric for individual humans.
Could you provide a few reputable clinical outcomes studies to support your statements? I was unaware of these risks.
These drugs require constant monitoring by physicians that understand what to look for, that are actively involved in adjusting dosage, for them to be even remotely safe. Muscle atrophy is considered an "uncommon side-effect", but that's just because most studies aren't performed over long enough periods of time. People tend to be kept on statins permanently. And that changes the safety factor considerably, as it does with any medicine taken over years.
My anecdotal evidence is based on multiple family members on these drugs and how even in Norway, with our fairly good healthcare system, it's not monitored sufficiently to avoid issues. There's a lot of strong feelings around statins as is apparent in the other response to my comment, but claims about them being safe except in outlier cases is simply not true.
See the bottom half of my comment at https://news.ycombinator.com/item?id=45446913 - significant muscle damage is exceedingly rare, and ~90% of the muscle pain reported in the RCTs ended up not being related to the statins at all.
Your claims are simply not backed by the data. These are some of the most prescribed and studied drugs on the planet.
These are some of the most studied medicines in human existence. They're not perfect and there are some people that do not tolerate them for one reason or another, but they are a small minority.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4876179/
https://pubmed.ncbi.nlm.nih.gov/36779348/
MR studies on genetics show that LDL and Lp(a) are independent risk factors for cardiovascular events regardless of hsCRP
https://www.nejm.org/doi/full/10.1056/NEJMoa1109034
https://pmc.ncbi.nlm.nih.gov/articles/PMC5483508/
https://europepmc.org/article/med/20032323
https://journals.plos.org/plosmedicine/article%3Fid%3D10.137...
The reputation for bad side effects with statins is basically entirely driven by early generation statins - we've got many that are far better suited for use today than things like lovastatin and similar. Rosuvastatin, pitavastatin, etc. are much less likely to cause any sort of issue for the vast majority of people.
Most of the side effects come at higher dosages, too, but most of the benefit comes from lower dosages. Combo therapy with lower dose statin + ezetimibe or bempadoic acid is becoming more and more popular for this reason.
https://www.lipidjournal.com/article/S1933-2874(25)00317-4/f...
> Based on the Cholesterol Treatment Trialists Collaboration meta-analysis of 27 statin RCT’s (statin vs placebo and high intensity vs moderate intensity statin), for every 1 mmol/L (∼39 mg/dL) reduction in LDL-C there is a corresponding 22% reduction in ASCVD event risk
Even people with "normal" LDL levels see reduction in risk. And people with high LDL levels might end up with a 3-4 nmol/L (or more!) reduction with combo therapy. Meanwhile statins are widely available, very cheap even without insurance, and as previously noted, have excellent side effect/safety/efficacy profiles for modern generations.
Your inaccurate information may be dissuading people who would otherwise get on these medications from doing so when it could literally be the difference between them living and dying. It's irresponsible.
2. Guess what the relative risk of myotoxicity is with statins.
I guess we're on repeat here. U and J shaped curves in observational studies are notorious for being confounded by reverse causality. They did attempt to control for some of the common factors, but cancer often goes undiagnosed, general frailty matches the age group and results in lower LDL levels, and some chronic inflammatory diseases also lower LDL and are not accounted for. CKD often lowers LDL levels due to malnutrition and decreased ability for the production of enzymes involved in lipid breakdown.
But let's dig deeper. Thankfully, we have other studies that help control for all of these factors and give us better evidence.
We have very large meta-analysis of high quality RCTs on statin use such as this one:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
All cause mortality dropped on top of cardiovascular related events and deaths. This is * alot* of data points showing a lack of increased mortality at LDL levels well below the 140 number in your linked study.
Let's go deeper still. The PCSK9 inhibitors are getting us to lower LDL via treatment than ever before:
https://pubmed.ncbi.nlm.nih.gov/36779348/
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/201...
Evolocumab got LDL down below 20 with better and better CVD related outcomes and no increased in all-cause mortality. Alirocumab taking LDL again, well below the 140 level, decreased all-cause mortality.
But we don't have to stop there. We can look at mendelian randomization studies - while RCTs are the gold standard for determining causal links, well designed MR are far far far superior to observational studies, and particularly when coupled with multiple signals they can be quite good at showing causal links. And that is the case here:
https://pubmed.ncbi.nlm.nih.gov/34729547/
https://pubmed.ncbi.nlm.nih.gov/33704808/
Increasing LDL-C levels = Decreasing lifespan
Observational studies in general are just not good evidence when it comes to all-cause mortality. It's too difficult to control for all of the different confounding factors and the amount of them with J and U shaped curves that do not match RCTs and MRs just shows that. It's the same with bf% - there are observational studies that show 25% bf is lower all-cause mortality than 15%, but there are no proposed mechanisms for that to be the case, no RCTs or MRs that show it to be the case, and for every confounding factor you eliminate the all-cause mortality rate increases at higher bf%.
> 2. Guess what the relative risk of myotoxicity is with statins.
Honestly? Basically not worth mentioning
https://pubmed.ncbi.nlm.nih.gov/36049498/
Blinded RCT/Meta-analysis shows about 11 complaints per 1k patient years, with 90% of them not actually being due to the statin. But because people act like they're common, they mistakenly believe it was the statin, which just reinforces this idea. And that's for muscle pain.
https://www.ahajournals.org/doi/10.1161/atv.0000000000000073
https://academic.oup.com/eurjpc/article-abstract/26/5/512/59...
https://pubmed.ncbi.nlm.nih.gov/15572716/
For actual significant muscle injury? Even lower. 1 or less per 10,000 patient years.
Effectively, you might get one muscle ache per year per 100 people and at most a 1 in 10,000 chance of serious myotoxicity.
The real risk with some statins is increasing your risk of diabetes - some of the older statins impair insulin resistance. But pitavastatin and rosuvastatin actually improve insulin sensitivity, and pravastatin is neutral. Pitavastatin in general has a significantly better side effect profile than other statins in basically every way. It is fairly under-prescribed in the US, though, due to the fact it has just recently become generic, and before that it was difficult to get insurance to cover it with the widespread availability of generic statins that were, honestly, already good enough for the overwhelming majority of use cases.
Additionally, the default treatment option is shifting more and more to combo therapy rather than ramping up statin doses. Most of the beneficial effect of statins comes relatively early on in the dosing curve, and the risk of side effects on the high end of it. You are more and more likely to see a low-dose statin and ezetimibe, which will generally have better LDL-C lowering capability with fewer side effects than a higher dose statin monotherapy. There are also additional options, such as the previously mentioned PCSK9 inhibitors and bempedoic acid that are not available as generics but can be added to therapy if necessary.
Seriously, please stop spreading misinformation about things. You might convince someone who needs a statin to not take one. This could literally be the difference between them dying from ASCVD or not.
I'm quite sure we would still see that cholesterol is useless and that inflammation drives everything.
The OVERWHELMING evidence is that cholesterol is a hugely important causal factor. Overwhelming to the point that we can't do controlled trials for people with CVD risk with cohorts not on a statin in this day and age - it wouldn't pass ethical review, because we have so much data. It is not ethical to withhold lifesaving medication from people when we know it is lifesaving.
The implication here is that the LDL-lowering effect of statins is greater than the CVE-reducing effect of statins. That is, if the statins lower your LDL by 30%, that doesn't bring your risk of heart disease the to the same level as someone who naturally has an identical lower LDL.
If you blocked your arteries before you got on a statin, it can stabilize the plaque and reduce the risk of rupture, reduce the ability for more to form and increase the blockage, and if it gets your LDL low enough, regress some of it, but it's not going to give you the same arteries as someone who never had that level of plaque deposition to begin with.
> Why? In some ways, cholesterol has become a victim of its own success. We now screen the whole population for high cholesterol, give statins to those with high LDL (or ApoB), and so then the majority of people who end up having heart attacks have lower cholesterol than they would naturally have
In other words, in the study population patients who would have had high LDL were likely to be on statins. The had a lower measured LDL value even though they might still be consuming a poor diet and living an unhealthy lifestyle, for example. Statins don't fix everything about poor diet and lifestyle, but they do help with cholesterol.
So don’t go throwing LDL out yet. It’s still the best measure we have, though you should obviously know that LDL measured while on statins is lower than it would be normally.
The headline, therefore, is somewhat clickbait from a company trying to sell these tests to you outside of your insurance. I recommend checking your insurance to see if the tests would be covered before you go the self-pay route.
Edit to add: If your doctor won't order hs-CRP for some reason, you can order it from sites like privatemdlabs.com for $50 (less if you take their 25% off coupon).